Human CD1d knock-in mouse model demonstrates potent antitumor potential of human CD1d-restricted invariant natural killer T cells.
about
Synthetic glycolipid activators of natural killer T cells as immunotherapeutic agentsImaging of NKT Cell Recirculation and Tissue Migration during Antimicrobial ImmunityNatural killer T cells in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitisImproving Mycobacterium bovis bacillus Calmette-Guèrin as a vaccine delivery vector for viral antigens by incorporation of glycolipid activators of NKT cellsCD4+ invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD4+CD25+FoxP3+ regulatory T cells.Chronic alcohol consumption enhances iNKT cell maturation and activationA Subset of CD8αβ+ Invariant NKT Cells in a Humanized Mouse ModelCXCL16-positive dendritic cells enhance invariant natural killer T cell-dependent IFNγ production and tumor controlHumanizing mice for the identification of novel anticancer lipids targeting iNKT cells.Different subsets of natural killer T cells may vary in their roles in health and disease.Optimizing NKT cell ligands as vaccine adjuvantsExploring the Therapeutic Potentials of iNKT Cells for Anti-HBV Treatment.Mouse models in oncoimmunology.A Novel Glycolipid Antigen for NKT Cells That Preferentially Induces IFN-γ Production.Innate immune cells for immunotherapy of autoimmune and cancer disorders.Alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 can support immune responses toward tumors overexpressing ganglioside D3 in mice.Murine CD8+ Invariant Natural Killer T Cells are Negatively Selected by CD1d Expressed on Thymic Epithelial Cells and Dendritic Cells.Dual Modifications of α-Galactosylceramide Synergize to Promote Activation of Human Invariant Natural Killer T Cells and Stimulate Anti-tumor Immunity.New Genetically Manipulated Mice Provide Insights Into the Development and Physiological Functions of Invariant Natural Killer T Cells.
P2860
Q26748456-C0B073FD-180F-4437-8C6B-45C0BDB3C847Q26799999-A6B3499F-829C-4FF6-98B5-9BE8E7751256Q28085038-444A1E46-F132-447D-BE98-334269AD498AQ28543248-6DA02EBC-64CA-4C5D-93A9-D8806C3439BCQ34551230-4A9FCA59-B3F1-418A-A410-89178A0DC971Q34987153-B198E453-3CCF-4245-BCD3-CC5B163B8F28Q35931493-1E318B3F-702D-42A0-BCB1-554FEA5D9295Q37079121-4BAE6FE5-3D50-439A-986F-52D13270EB67Q37265576-F8764E87-B7E4-4531-8512-92F24EACA41FQ38178734-CCD3C11B-45BB-4EFE-850A-FAC9DB1823B7Q38206819-0724236D-F44C-4B2A-B78B-4B42240D98BDQ38273315-9A69E1E0-C2D1-4148-AFDD-A50A89195845Q38968582-1439CCFC-A6B5-47D8-B544-D6F1F53D30B0Q40832140-6A770967-5FAF-42B7-87D9-875A4976EE1AQ48316500-A82F5FBC-70C7-4201-AF7E-9D1CDCA7E9A0Q48954516-D68F0AA5-0AE6-4629-AAAE-1A535AC99EB8Q50425147-3B45D0DB-F8C8-4ACC-911E-FD3FBCDE3AF2Q53077248-5EC45990-5836-4B69-8401-41DCE177431BQ55491557-B3B95366-16C9-4B2E-BEFA-B4AFD25CFEB6
P2860
Human CD1d knock-in mouse model demonstrates potent antitumor potential of human CD1d-restricted invariant natural killer T cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Human CD1d knock-in mouse mode ...... ariant natural killer T cells.
@ast
Human CD1d knock-in mouse mode ...... ariant natural killer T cells.
@en
type
label
Human CD1d knock-in mouse mode ...... ariant natural killer T cells.
@ast
Human CD1d knock-in mouse mode ...... ariant natural killer T cells.
@en
prefLabel
Human CD1d knock-in mouse mode ...... ariant natural killer T cells.
@ast
Human CD1d knock-in mouse mode ...... ariant natural killer T cells.
@en
P2093
P2860
P356
P1476
Human CD1d knock-in mouse mode ...... ariant natural killer T cells.
@en
P2093
Agnieszka Lawrenczyk
Leandro J Carreño
Peter Cresswell
Weiming Yuan
Xiangshu Wen
P2860
P304
P356
10.1073/PNAS.1300200110
P407
P577
2013-02-04T00:00:00Z